Milestone and contract revenues — Total revenues
Incyte Milestone and contract revenues — Total revenues decreased by 83.0% to $17.00M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Milestone and contract revenues — Total revenues shows an upward trend with a 12.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful achievement of clinical or regulatory milestones within the company's partnership portfolio, while a decrease suggests a lack of recent development triggers or the completion of major contract phases.
Detailed definition
This metric represents the portion of total revenue derived from contractual milestone payments, such as those triggered...
Peer comparison
Peers in the biotechnology and pharmaceutical sector often report similar 'collaboration revenue' or 'milestone payments' which vary significantly based on the maturity of the drug pipeline and the structure of licensing deals.
incy_segment_milestone_and_contract_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.75M | $23.75M | $23.75M | $41.25M | $41.25M | $41.25M | $41.25M | $0.00 | $0.00 | $5.00M | $2.00M | $25.00M | $0.00 | $18.00M | $0.00 | $0.00 | $5.00M | $45.00M | $100.00M | $17.00M |
| QoQ Change | — | +0.0% | +0.0% | +73.7% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | -60.0% | >999% | -100.0% | — | -100.0% | — | — | +800.0% | +122.2% | -83.0% |
| YoY Change | — | — | — | — | +73.7% | +73.7% | +73.7% | -100.0% | -100.0% | -87.9% | -95.2% | — | — | +260.0% | -100.0% | -100.0% | — | +150.0% | — | — |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's milestone and contract revenues — total revenues?
- Incyte (INCY) reported milestone and contract revenues — total revenues of $17.00M in Q1 2026.
- What is the long-term trend for Incyte's milestone and contract revenues — total revenues?
- Over 4 years (2021 to 2025), Incyte's milestone and contract revenues — total revenues has grown at a 12.1% compound annual growth rate (CAGR), from $95.00M to $150.00M.
- What does milestone and contract revenues — total revenues mean?
- Revenue earned from achieving specific development or commercial goals defined in licensing and collaboration agreements.